Loading…
cbdMD, Inc. is projected to decline to $0.7191 by 2027, a -6% move from its current price of $0.765. YCBD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.7392 | $0.7652 | $0.7922 | +0.03% |
| May 30 | $0.7289 | $0.7655 | $0.8039 | +0.06% |
| May 31 | $0.7211 | $0.7657 | $0.813 | +0.09% |
| Jun 1 | $0.7147 | $0.7659 | $0.8209 | +0.12% |
| Jun 2 | $0.7091 | $0.7662 | $0.8278 | +0.15% |
| Jun 3 | $0.7041 | $0.7664 | $0.8342 | +0.18% |
| Jun 4 | $0.6995 | $0.7666 | $0.8402 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6995 | $0.7666 | $0.8402 | +0.21% |
| Week 2 | $0.6749 | $0.7683 | $0.8745 | +0.43% |
| Week 3 | $0.657 | $0.7699 | $0.9023 | +0.65% |
| Week 4 | $0.6424 | $0.7716 | $0.9267 | +0.86% |
| Week 5 | $0.63 | $0.7733 | $0.949 | +1.08% |
| Week 6 | $0.6192 | $0.7749 | $0.9698 | +1.30% |
| Week 7 | $0.6094 | $0.7766 | $0.9895 | +1.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
cbdMD, Inc. is a healthcare company trading under the symbol YCBD. It produces and distributes cannabidiol (CBD) products in the United States and internationally, and it owns and operates several consumer hemp-based CBD brands.
Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand.
The company serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. It is based in Charlotte, North Carolina and was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019.
cbdMD, Inc. trades as YCBD. The current price is $0.7609 per share, with a market capitalization of $7.99M, and it ranks 5224.
The forecast shows a neutral near-term path, with 2026 having an average price of $0.7609 and ROI 0, sentiment Neutral. The 30-day outlook suggests a gradual drift in the 2027-2029 window, where the average prices range lower (to $0.604 by 2029) and sentiment shifts toward Bearish in 2029.
Looking further out, the 2030 forecast shows an average price of $0.702 with ROI -7.7 and Neutral sentiment, followed by more pronounced gains in 2040 (average $1.21, ROI 59.3, Bullish) and 2050 (average $1.80, ROI 136.5, Bullish). The forecast also lists optimistic max prices later (2040 max $2.27, 2050 max $3.76).
A major floor 24.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.4% away) — a key level to hold.
The nearest ceiling, 32.0% above — a clean break opens room to run.
A major ceiling 44.3% above — clearing it would confirm fresh momentum.
Key YCBD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of YCBD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7626 | Buy | $0.765 | Buy |
| MA 10 | $0.7706 | Sell | $0.7766 | Sell |
| MA 20 | $0.8117 | Sell | $0.7954 | Sell |
| MA 50 | $0.7906 | Sell | $0.8095 | Sell |
| MA 100 | $0.835 | Sell | $0.8441 | Sell |
| MA 200 | $0.8751 | Sell | $1.11 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.21 | Neutral |
| Stoch RSI (14) | 27.22 | Neutral |
| CCI (20) | -70.37 | Neutral |
| Williams %R (14) | -86.07 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -8.93 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 13.93 | Buy |
| TRIX (15) | -0.13 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 41.85 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 0.76 | Buy |
| ADX (14) | 12.15 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is Bearish. RSI(14) is 40, suggesting modest downside pressure as momentum weakens. The 50-day simple moving average stands at $0.7887, with the 200-day moving average at $0.876, indicating price staying below the longer-term trend.
Support is listed at $0.728 and resistance at $1.01, framing a trading range near the current level. The 30-day price range is $0.5974 to $0.9692, illustrating recent volatility. Annualized volatility is 70, underscoring elevated price swings in this period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.654 | $0.765 | $0.8968 | 0% | Neutral | |
| $0.5555 | $0.7191 | $0.9944 | -6% | Neutral | |
| $0.5098 | $0.6837 | $0.9875 | -11% | Neutral | |
| $0.454 | $0.6274 | $0.9377 | -18% | Bearish | |
| $0.5012 | $0.7114 | $1.09 | -7% | Neutral | |
| $0.5825 | $0.8473 | $1.34 | +11% | Neutral | |
| $0.613 | $0.9126 | $1.47 | +19% | Neutral | |
| $0.5713 | $0.8692 | $1.43 | +14% | Neutral | |
| $0.534 | $0.8297 | $1.39 | +8% | Neutral | |
| $0.5386 | $0.8538 | $1.46 | +12% | Neutral | |
| $0.7122 | $1.24 | $2.27 | +62% | Bullish | |
| $0.9056 | $1.86 | $3.78 | +143% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.654 | $0.765 | $0.8987 | +0.00% |
| June 2026 | $0.6496 | $0.7674 | $0.9313 | +0.31% |
| July 2026 | $0.6589 | $0.7867 | $0.971 | +2.52% |
| August 2026 | $0.6322 | $0.7613 | $0.9519 | -3.23% |
| September 2026 | $0.5962 | $0.7229 | $0.9134 | -5.05% |
| October 2026 | $0.5924 | $0.723 | $0.9222 | +0.02% |
| November 2026 | $0.5889 | $0.7228 | $0.9296 | -0.03% |
| December 2026 | $0.5607 | $0.6919 | $0.8968 | -4.27% |
Click any year to see its month-by-month YCBD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, YCBD is projected to trade between $0.654 and $0.8968, averaging $0.765 — a potential gain of 0% from today's $0.765. A consolidation phase looks the most probable path here.
cbdMD, Inc.'s 2027 outlook centres on $0.7191, within a $0.5555 to $0.9944 range. That is -6% versus the projected 2026 average. That marks a -6% change versus current levels. Price action looks broadly range-bound.
By 2028, YCBD could reach as high as $0.9875, with a base case around $0.6837 and support toward $0.5098 — roughly -11% from $0.765. A consolidation phase looks the most probable path here.
Expect YCBD to range from $0.454 to $0.9377 through 2029. The $0.6274 average target implies a -18% move from current prices. That is -8% versus the projected 2028 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The YCBD price prediction for 2030 points to an average of $0.7114 (low $0.5012, high $1.09) — a potential decline of -7% on today's $0.765. A consolidation phase looks the most probable path here.
In 2031, YCBD is projected to trade between $0.5825 and $1.34, averaging $0.8473 — a potential gain of +11% from today's $0.765. That is up +19% on the projected 2030 average. Price action looks broadly range-bound.
cbdMD, Inc.'s 2032 outlook centres on $0.9126, within a $0.613 to $1.47 range. That is up +8% on the projected 2031 average. That marks a +19% change versus current levels. A consolidation phase looks the most probable path here.
By 2033, YCBD could reach as high as $1.43, with a base case around $0.8692 and support toward $0.5713 — roughly +14% from $0.765. Price action looks broadly range-bound.
Expect YCBD to range from $0.534 to $1.39 through 2034. The $0.8297 average target implies a +8% move from current prices. That is -5% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The YCBD price prediction for 2035 points to an average of $0.8538 (low $0.5386, high $1.46) — a potential gain of +12% on today's $0.765. Price action looks broadly range-bound.
In 2040, YCBD is projected to trade between $0.7122 and $2.27, averaging $1.24 — a potential gain of +62% from today's $0.765. That is up +45% on the projected 2035 average. Buyers look set to stay in control over this stretch.
cbdMD, Inc.'s 2050 outlook centres on $1.86, within a $0.9056 to $3.78 range. That is up +50% on the projected 2040 average. That marks a +143% change versus current levels. Momentum favours further upside here.
Investing $1,000 in YCBD today (≈ 1,307.189542 YCBD) could be worth
$2,429.88
+$1,429.88 (+143%) by 2050 · US Dollar
Based on the average projected YCBD price of $1.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in YCBDwould be worth at today's price.
$1,000 invested in YCBD on May 27, 2025 (≈ 1,038.4216 YCBD) would be worth
$794.39
-$205.61 (-20.6%) today · 0.79× · US Dollar
Based on a YCBD entry price of $0.963 vs. today's $0.765.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.748 | $1,022.73 | +2.3% |
| 1 month ago | $0.97 | $788.66 | -21.1% |
| 3 months ago | $0.989 | $773.51 | -22.6% |
| 6 months ago | $0.618 | $1,237.86 | +23.8% |
| 1 year ago | $0.963 | $794.39 | -20.6% |
| All time (5.0y) ago | $1,054.8 | $0.73 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our YCBD forecast.
Our base-case forecast reaches $1.50 around 2050.
Implied market cap at $1.50: $15.75M
The multi-year forecast shows a mixed to improving path after a downturn through 2029. For 2026–2029, the averages are $0.7609 (ROI 0), $0.7167 (ROI -5.8), $0.6715 (ROI -11.8), and $0.604 (ROI -20.6), with sentiment Neutral in those years except 2029 which is Bearish.
In 2030, the forecast yields an average price of $0.702 with ROI -7.7 and Neutral sentiment, signaling near-term softness. The trajectory turns more favorable in 2040, with an average of $1.21 and ROI 59.3, accompanied by a Bullish sentiment. By 2050, the average is $1.80 with ROI 136.5 and Bullish sentiment, supported by higher potential upside in the far horizon.
In absolute terms, the max prices also rise in the later years, with 2040 max $2.27 and 2050 max $3.76, highlighting potential upside if the longer-term trend plays out.” ,
Tap a question to reveal the answer.
2030 average price is $0.702; min $0.4874; max $1.10; ROI -7.7; sentiment Neutral.
Near-term outlook is Neutral through 2026–2028, with a Bearish year in 2029, followed by Neutral in 2030–2035. Longer term, the forecast turns Bullish by 2040 (avg $1.21, ROI 59.3) and by 2050 (avg $1.80, ROI 136.5).
Yes. The forecast max prices include $2.27 in 2040 and $3.76 in 2050, indicating potential for the price to exceed $2 in the longer term.
Current price is $0.7609 per share and market cap is $7.99M. The stock ranks 5224 by market cap.
Annualized volatility is 70. The 30-day range is from $0.5974 to $0.9692, reflecting notable near-term price swings.
cbdMD, Inc. Community Discussion
0Share your cbdMD, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.